GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
THG
Who owns THG today?
The fall and partial recovery of THG after its 2020 IPO exposed tensions in founder-led governance and concentrated voting power. A near-90% peak-to-trough share collapse raised questions about control, transparency and the value of the Ingenuity platform.
Current ownership mixes founder Matthew Moulding’s significant stake and voting rights, institutional investors, activist funds and strategic partners as THG explores demerger options in 2025–2026; see THG Porter's Five Forces Analysis for related insight.
Who Founded THG?
Founders and Early Ownership of THG were defined by a tightly held, founder-led capital structure centered on Matthew Moulding and John Gallemore, with a reinvestment-first approach that prioritized brand roll-up and platform growth over early dividends.
THG was founded in 2004 by Matthew Moulding and John Gallemore, with Moulding acting as the dominant equity holder and operational leader.
The business began lean and bootstrapped, channeling operating cash flow into acquiring consumer brands rather than paying dividends.
Early high-profile supporters included Sir Terry Leahy and Bill Currie, who supplied capital and retail credibility during the pivot from media to consumer goods.
THG avoided major VC dilution in its first decade, using targeted debt and minority equity from firms like KKR and Old Mutual Global Investors.
Early financing agreements commonly included provisions safeguarding Moulding's operational autonomy and strategic control.
By the pre-IPO phase ownership was concentrated among founders, executives and long-term associates, setting up the later Golden Share governance model.
Early ownership choices shaped THG ownership and the THG Group structure, concentrating power with the founders while bringing in strategic investors to fuel rapid category expansion.
The founding and early funding era established the ownership baseline that later influenced public listing dynamics and shareholder debates.
- 2004 founding by Matthew Moulding and John Gallemore with founder-majority control.
- Early angel investors included Sir Terry Leahy and Bill Currie for capital and retail expertise.
- Strategic minority investments from KKR and Old Mutual supported growth without ceding control.
- Pre-IPO ownership remained concentrated, enabling the Golden Share and founder-led governance at flotation.
For details on THG business lines and revenue mix that contextualize these ownership decisions see Revenue Streams & Business Model of THG
Complete THG Strategy Bundle
- 6 Full Frameworks, 1 Company – All Pre-Researched
- Each Framework Fully Sourced with Real Company Data
- Built for Strategy Courses, Case Studies & MBA Programs
- Adapt to Your Assignment – No Starting from Scratch
- 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
How Has THG’s Ownership Changed Over Time?
The ownership of THG shifted dramatically after the September 2020 IPO that raised £1.88bn, then continued to evolve as strategic investors and activists acquired stakes; major events include SoftBank’s exit in 2022, Frasers Group’s strategic build in 2023–24, and activist pressure from Kelso in 2023–24.
| Stakeholder | Approx. Holding (mid‑2025) | Role / Notes |
|---|---|---|
| Matthew Moulding | 12–15% | Founder and primary individual shareholder; ongoing executive influence |
| Frasers Group (Mike Ashley) | ~10% | Strategic investor; integrated Ingenuity with Frasers' retail operations |
| Qatar Investment Authority (QIA) | ~7% | Sovereign wealth investor providing long‑term institutional support |
| Schroder Investment Management & other asset managers | Various (collective institutional holdings) | Passive and active institutional investors shaping governance expectations |
| Kelso Group | Minority stake (single‑digit) | Activist investor pushing for demerger of nutrition and beauty divisions |
| SB Northstar (SoftBank) | 0% (sold) | Exited ~8% stake at a loss in 2022, signaling reduced tech‑conglomerate appetite |
These shifts transformed THG from a founder‑led private group to a publicly traded company contested by strategic retail partners, sovereign investors and activists, altering the THG Group structure and investor mix.
Major stakes and exits since the 2020 IPO reshaped control dynamics and strategic options for THG.
- 2020 IPO raised £1.88bn, diversifying THG ownership
- SoftBank’s SB Northstar sold its ~8% stake in 2022
- Frasers Group accumulated ~10% in 2023–24 and linked Ingenuity to its retail network
- Kelso Group pushed for demerger via minority holdings in 2023–24
For more on THG’s strategic positioning and board intent alongside ownership changes, see Mission, Vision & Core Values of THG
From PESTLE Factors to Full Strategy Bundle
- PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
- Every Strategic Angle Covered – Nothing Left to Research
- Pre-filled with Company-Specific Research
- No Missing Sections for Your Case Study
- One Download Covers Your Entire Company Analysis
Who Sits on THG’s Board?
The current THG board is chaired by Charles Allen, with founder Matthew Moulding serving as CEO and John Gallemore as COO; the board includes multiple independent non-executive directors aimed at strengthening corporate governance and balancing founder influence.
| Director | Role | Notes |
|---|---|---|
| Charles Allen, Lord Allen of Kensington | Chair | Appointed to professionalize governance and oversee strategy |
| Matthew Moulding | Chief Executive Officer | Founder; significant economic stake and ongoing strategic influence |
| John Gallemore | Chief Operating Officer | Operational lead; central to proposed spin-offs including THG Nutrition |
| Independent Non-Executive Directors | Various | Suite of independents added to meet Premium Listing standards |
Governance shifted materially in 2024 when THG moved to a Premium Listing, relinquishing the founder 'Golden Share' and adopting a one-share, one-vote regime; this change aimed to improve ESG ratings and FTSE eligibility while leaving practical influence concentrated among key shareholders.
The board now operates under normalized voting rights, but founder alliances and major investors still shape outcomes for strategic actions.
- One-share, one-vote adopted in 2024 after Premium Listing conversion
- Matthew Moulding retains significant voting influence through direct holdings
- Strategic allies, including Frasers Group, amplify combined voting power on key votes
- Activist investors such as Kelso Group press for board changes and asset realization
As of late 2025 filings, the top institutional shareholders included figures aligned with strategic partners and institutional investors holding collective stakes sufficient to influence major corporate actions; for further context on THG ownership and investor pressures see Marketing Strategy of THG.
THG Business Model + Strategy Bundle
- Ideal for Essays, Case Studies & Slides
- Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
- Company-Specific Content Already Organized
- One Bundle Replaces Days of Independent Research
- Buy the Bundle Once. Use Across All Your Assignments
What Recent Changes Have Shaped THG’s Ownership Landscape?
Between 2024 and 2025 THG’s ownership profile shifted toward structural simplification and value realization, driven by board plans for a demerger of THG Nutrition (Myprotein) and potential separation of THG Beauty. Market commentary and selective buybacks signalled moves to unlock value and reframe THG ownership for investor clarity.
| Development | Implication | Key parties |
|---|---|---|
| Planned demerger of THG Nutrition (Myprotein) | Standalone valuation uplift; attracts consumer-focused institutional investors | Board, Matthew Moulding, institutional investors |
| Potential later demerger of THG Beauty | Further simplification; clearer comparables and multiples | Board, sell-side analysts |
| Frasers Group consolidation signals | Possible increased stake or asset-level acquisitions (logistics) | Frasers Group, major shareholders |
| Selective share buybacks (2024–25) | Stock stabilisation but modest vs market cap | THG plc treasury actions |
| Founder dilution via demerger (projected to 2026) | Matthew Moulding trades absolute conglomerate control for concentrated stakes | Founder, new independent company shareholders |
Analysts in 2025 estimated a standalone Myprotein could command a valuation multiple of roughly 2–3x the group’s current EV/EBITDA, while THG’s consolidated market cap remained depressed versus peers; latest disclosed major holders in 2025 included Frasers Group, institutional investors and founder-related vehicles, with public filings showing founder-linked holdings diluted but still influential.
Board statements at the 2025 AGM stressed a commitment to a simplified corporate structure to improve transparency for THG investors and potential acquirers.
Separations increase appeal to consumer-focused funds; analysts note a rotation into standalone consumer names among UK investors.
Projected founder dilution through demerger keeps Matthew Moulding as a material shareholder but reduces conglomerate control in favour of traditional equity stakes.
See the Growth Strategy of THG article for detailed context on the demerger rationale and market positioning.
From Five Forces to Full Company Analysis
- Includes SWOT, PESTLE, BMC, BCG and 4P's
- Pre-Researched with Company-Specific Data
- Best Value for a Complete Analysis
- Ready to Adapt for Your Case Study
- Ready for Essays and Slidesd
- What is Brief History of THG Company?
- What is Competitive Landscape of THG Company?
- What is Growth Strategy and Future Prospects of THG Company?
- How Does THG Company Work?
- What is Sales and Marketing Strategy of THG Company?
- What are Mission Vision & Core Values of THG Company?
- What is Customer Demographics and Target Market of THG Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.